Nanoviricides (NNVC) Other Operating Expenses (2011 - 2025)
Nanoviricides (NNVC) posted Other Operating Expenses of -$2000.0 for Q3 2025, little changed sequentially from -$2000.0 in Q3 2024, and little changed YoY from -$2000.0 in Q3 2024.
Nanoviricides (NNVC) Other Operating Expenses (2011 - 2025) Analysis & Trends
Nanoviricides has reported Other Operating Expenses for 11 years, with the latest figure at -$2000.0 in Q3 2025.
- Quarterly Other Operating Expenses changed 0.0% year-over-year to -$2000.0 in Q3 2025, while the trailing twelve-month figure through Mar 2026 was -$2000.0 (changed 0.0% YoY) and the FY2025 annual result came in at -$2000.0, changed 0.0% from the prior year.
- Other Operating Expenses was little changed at -$2000.0 in Q3 2025 per NNVC's latest filing, from -$2000.0 in the prior quarter.
- Over five years, Other Operating Expenses peaked at $6.2 million in Q2 2023 and troughed at -$2000.0 in Q3 2021.
- A 5-year average of $1.0 million and a median of -$2000.0 in 2021 frame the typical range for Other Operating Expenses.
- The widest YoY moves for Other Operating Expenses: up 0.0% in 2021, down 0.0% in 2021.
- Over 5 years, Other Operating Expenses stood at -$2000.0 in 2021, then changed by 0.0% to -$2000.0 in 2022, then changed by 0.0% to -$2000.0 in 2023, then changed by 0.0% to -$2000.0 in 2024, then changed by 0.0% to -$2000.0 in 2025.
- According to Business Quant data, Other Operating Expenses over the past three periods registered -$2000.0, -$2000.0, and -$2000.0 for Q3 2025, Q3 2024, and Q3 2023 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Nanoviricides | 28.74 Mn | 25.53 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -2,000.00 |
| Sep 30, 2024 | -2,000.00 |
| Sep 30, 2023 | -2,000.00 |
| Jun 30, 2023 | 6.24 Mn |
| Sep 30, 2022 | -2,000.00 |
| Sep 30, 2021 | -2,000.00 |
| Dec 31, 2020 | -2,026.00 |
| Sep 30, 2020 | -2,000.00 |
| Dec 31, 2019 | -2,000.00 |
| Sep 30, 2019 | -2,000.00 |
| Jun 30, 2014 | 348,784.00 |
| Jun 30, 2013 | -26,475.00 |
| Jun 30, 2012 | 1.01 Mn |
| Jun 30, 2011 | -42,265.00 |
| Mar 31, 2011 | 42,265.00 |